Legend Biotech Corp (LEGN) Net Margin (2019 - 2025)

Legend Biotech (LEGN) has reported Net Margin for 7 consecutive years, with 0.82% the latest figure, recorded in Q4 2025.

• Net Margin for Q4 2025 came in at 0.82%, up 3245.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.24% (up 965.0% YoY), and the FY2025 annual result was 3.22%, up 2688.0% from the prior year.
• Net Margin was 0.82% for Q4 2025 at Legend Biotech, up from 0.0% in the prior quarter.
• Over five years, Net Margin peaked at 852.93% in Q2 2021 and troughed at 738.96% in Q3 2021.
• Average Net Margin over 5 years is 7.21%, with a median of 0.0% recorded in 2025.
• Year-over-year, Net Margin surged 201566 bps in 2021 and tumbled 85292 bps in 2022.
• Over 5 years, Net Margin stood at 226.53% in 2021, then soared by 100 bps to 0.0% in 2022, then plunged by 7509948 bps to 0.11% in 2023, then plunged by 28291 bps to 31.64% in 2024, then surged by 103 bps to 0.82% in 2025.
• Per Business Quant data, the three most recent Net Margin figures were 0.82% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.